Immune signatures of treatment response and immune-related adverse events in melanoma patients under checkpoint inhibitor therapy

被引：0
|
作者：
Reschke, R. [1 ]
Gussek, P. [1 ]
Boldt, A. [2 ]
Sack, U. [2 ]
Koehl, U. [2 ,3 ]
Lordick, F. [4 ,5 ]
Kreuz, M. [3 ]
Reiche, K. [3 ]
Simon, J. C. [1 ]
Ziemer, M. [1 ]
Kunz, M. [1 ]
机构：
[1] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany
[2] Univ Leipzig, Inst Clin Immunol, D-04103 Leipzig, Germany
[3] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany
[4] Univ Leipzig, Dept Oncol Gastroenterol Hepatol Pulmonol & Infec, D-04103 Leipzig, Germany
[5] Univ Canc Ctr Leipzig, D-04103 Leipzig, Germany
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P113
引用
收藏
页码：E57 / E57
页数：1
相关论文
共 50 条
  • [1] Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Reschke, Robin
    Gussek, Philipp
    Boldt, Andreas
    Sack, Ulrich
    Koehl, Ulrike
    Lordick, Florian
    Gora, Thomas
    Kreuz, Markus
    Reiche, Kristin
    Simon, Jan-Christoph
    Ziemer, Mirjana
    Kunz, Manfred
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [2] T-Cell Subtypes and Immune Signatures in Cutaneous Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor Therapy
    Absmaier-Kijak, Magdalena
    Iuliano, Caterina
    Kaesler, Susanne
    Biedermann, Tilo
    Posch, Christian
    Brockow, Knut
    CANCERS, 2024, 16 (06)
  • [3] Response to treatment of cutaneous immune-related adverse events following immune checkpoint inhibitor therapy
    Reardon, R. M.
    Perlman, K. L.
    Asdourian, M.
    Shah, N.
    Jacoby, T.
    Thompson, L. L.
    Reynolds, K.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S87 - S87
  • [4] Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Therapy
    Ho, Adrienne K.
    Ho, Anthony M-H
    Cooksley, Tim
    Nguyen, Giang
    Erb, Jason
    Mizubuti, Glenio B.
    ANESTHESIA AND ANALGESIA, 2021, 132 (02): : 374 - 383
  • [5] AUTOANTIBODY BIOMARKERS OF IMMUNE-RELATED ADVERSE EVENTS AND SURVIVAL IN MELANOMA PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITOR THERAPY
    Aude, C.
    Ghosh, N.
    Jannat-Khah, D.
    Chan, K. K.
    Postow, M.
    Larman, H.
    Bass, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1188 - 1189
  • [6] Longitudinal immune and genomic monitoring reveals signatures of response and Immune-related adverse events in cancer patients receiving checkpoint inhibitor therapy
    Khan, Shaheen
    Gerber, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Pancreatic Immune-Related Adverse Events Due to Immune Checkpoint Inhibitor Therapy
    Patel, Vanisha
    Ashkar, Motaz
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S714 - S714
  • [8] Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy
    Saliba, Antoine N.
    Xie, Zhuoer
    Higgins, Alexandra S.
    Andrade-Gonzalez, Xavier A.
    Fuentes-Bayne, Harry E.
    Hampel, Paul J.
    Kankeu Fonkoua, Lionel A.
    Childs, Daniel S.
    Rakshit, Sagar
    Bezerra, Evandro D.
    Kommalapati, Anuhya
    Lou, Yanyan
    Rivera, Candido E.
    Price, Katharine A.
    Chintakuntlawar, Ashish
    Yan, Yiyi
    Schwecke, Anna J.
    Block, Matthew S.
    Thanarajasingam, Uma
    Thanarajasingam, Gita
    Wolanskyj-Spinner, Alexandra P.
    Marshall, Ariela L.
    Kottschade, Lisa A.
    Go, Ronald S.
    Al-Kali, Aref
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (10) : E362 - E367
  • [9] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [10] Association of immune-related adverse events with immune-checkpoint inhibitors and treatment response in melanoma patients.
    Rodriguez, Benigno
    Martinez-Herrera, Jose Fabian
    Zepeda, Lorena Lopez
    Olivares, Guillermo
    Villalobos, Alberto
    Perez, Fernando
    Limas, Christian Patricio Camacho
    Serrano, Juan Alberto
    Villamayor, Omar Serrano
    Lopez, Ervin Saul Enciso
    Gerson, Daniela Shveid
    Sanchez, Efrain Isaias Camarin
    Molina, Diana Bonilla
    Cabrera, Juan Manuel Tovar
    Nehmad, Cecilia
    Whaley, Juan Jose Juarez -Vignon
    Gerson, Raquel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345